Dr Mark Dowling is a clinical haematologist within the CAR-T stream at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital, and a clinician scientist within the Centre of Excellence for Cellular Immunotherapy (CoE CIT) Translational Laboratory. With support from a Victorian Cancer Agency (VCA) mid-career fellowship, he is developing novel immunotherapy trials in lymphoma and myeloma. He has a passion for translational research and is dedicated to improving outcomes for patients with blood cancer.
